Buiret Guillaume, Thomas-Danguin Thierry, Feron Gilles
Service ORL Et Chirurgie Cervicofaciale, Centre Hospitalier de Valence, 179 Boulevard du Maréchal Juin, 26953, Valence, France.
Centre Des Sciences du Goût Et de L'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21000, Dijon, France.
Support Care Cancer. 2022 Jul;30(7):5691-5702. doi: 10.1007/s00520-022-06904-y. Epub 2022 Feb 22.
Metallic taste (MT) is a taste abnormality often reported by cancer patients. The aim of this systematic review was to exhaustively report MT incidences in cancer patients and to evaluate the risk of bias in the pertinent studies in accordance with a meta-analysis approach.
The research objective was to determine the prevalence of MT in patients treated for cancer. A literature search was conducted using PubMed, Web of Science, and Embase. The authors each screened articles and evaluated the eligibility and individual risk of bias for each article. Then, all of the results were compared. A meta-analysis was conducted on studies that specifically focused on MT evaluation.
Very few articles have been published on the incidence of MT among taste and smell abnormalities in cancerology (22 of 1674, 1.3%), and the quality of the reports on MT was often low. The most common bias was the methodology used for MT evaluation. Pooling the results of the 22 studies led to an estimated MT incidence in the cancer patient population of 29% (95% CI [0.21; 0.39]) with high and significant heterogeneity observed among the studies. A heterogeneity analysis was performed to identify the causal factors of this heterogeneity. The specific impact of MT on nutritional status (two) and quality of life (five) studies were reported, respectively, and without a specific evaluation of MT. There was no mention of oral health in any of the studies.
Although in clinical practice cancer patients often report MT, its incidence has only been reported in 22 studies, most of which have a moderate to severe risk of bias. Considering the rather high prevalence of MT, more research should be conducted in this field to better identify its causes and mechanisms.
金属味觉(MT)是癌症患者常报告的味觉异常。本系统评价的目的是详尽报告癌症患者中MT的发生率,并根据荟萃分析方法评估相关研究中的偏倚风险。
研究目的是确定接受癌症治疗患者中MT的患病率。使用PubMed、科学网和Embase进行文献检索。作者各自筛选文章并评估每篇文章的合格性和个体偏倚风险。然后,比较所有结果。对专门关注MT评估的研究进行荟萃分析。
在肿瘤学中关于味觉和嗅觉异常中MT发生率的文章发表极少(1674篇中的22篇,1.3%),且关于MT的报告质量通常较低。最常见的偏倚是用于MT评估的方法。汇总22项研究的结果得出癌症患者群体中MT的估计发生率为29%(95%CI[0.21;0.39]),各研究间观察到高度且显著的异质性。进行异质性分析以确定这种异质性的因果因素。分别报告了MT对营养状况(两项)和生活质量(五项)研究的具体影响,且未对MT进行具体评估。所有研究均未提及口腔健康。
尽管在临床实践中癌症患者常报告MT,但其发生率仅在22项研究中被报道,其中大多数存在中度至重度偏倚风险。考虑到MT的患病率相当高,该领域应开展更多研究以更好地确定其原因和机制。